{"url_path":"/sec/kblb/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1413119/0001493152-26-023130-index.html","accession_number":"0001493152-26-023130","cik":"0001413119","ticker":"KBLB","issuer_name":"Kraig Biocraft Laboratories, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1413119/0001493152-26-023130-index.html","primary_entity_key":"0001413119","primary_entity_name":"Kraig Biocraft Laboratories, Inc."},"word_count":646,"has_tables":true,"body_markdown":"**ITEM\n6. EXHIBITS**\n\n \n\nEXHIBIT\nINDEX\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n3.1\n \n[Articles\nof Incorporation (1)](https://www.sec.gov/Archives/edgar/data/1413119/000121390007001269/fsb20907ex3i_kraig.htm)\n\n3.2\n \n[Articles\nof Amendment (2)](https://www.sec.gov/Archives/edgar/data/1413119/000121390009002710/fs1ex3ii_kraigbio.htm)\n\n3.3\n \n[Articles\nof Amendment, filed with the Wyoming Secretary of State on November 15, 2013 (3)](https://www.sec.gov/Archives/edgar/data/1413119/000135448813006603/kblb_ex31.htm)\n\n3.4\n \n[Articles\nof Amendment, filed with the Wyoming Secretary of State on December 17, 2013 (4)](https://www.sec.gov/Archives/edgar/data/1413119/000135448813006955/kblb_ex31.htm)\n\n3.5\n \n[Bylaws\n(1)](https://www.sec.gov/Archives/edgar/data/1413119/000121390007001269/fsb20907ex3ii_kraig.htm)\n\n4.1\n \n[Form\nof Warrant issued Mr. Jonathan R. Rice (5)](https://www.sec.gov/Archives/edgar/data/1413119/000135448815001479/kblb_ex41.htm)\n\n4.2\n \n[Form\nof Warrant issued pursuant to that certain Purchase Agreement dated as of March 8, 2019 (7)](https://www.sec.gov/Archives/edgar/data/1413119/000165495419002552/regswarrant.htm)\n\n4.3\n \n[Form\nof Convertible Debenture (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex4-1.htm)\n\n4.4\n \n[Form\nof Warrant (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex4-2.htm)\n\n4.5\n \n[Form\nof A&R Convertible Debenture (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex4-3.htm)\n\n10.1\n \n[Employment\nAgreement between Mr. Jonathan Rice and the Company (6)](https://www.sec.gov/Archives/edgar/data/1413119/000135448815000262/ex_101.htm)\n\n10.2\n \n[Form\nof Purchase Agreement dated March 8, 2019 (7)](https://www.sec.gov/Archives/edgar/data/1413119/000165495419002552/kraig-regsspa.htm)\n\n10.3\n \n[Form\nof Securities Purchase Agreement (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex10-1.htm)\n\n10.4\n \n[Form\nof Guaranty Agreement (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex10-2.htm)\n\n10.5\n \n[Form\nof Security Agreement (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex10-3.htm)\n\n10.6\n \n[Form\nof IP Security Agreement (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex10-4.htm)\n\n10.7\n \n[Form\nof Registration Rights Agreement (8)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221006956/ex10-5.htm)\n\n10.8\n \n[Strategic\nPartnership Agreement (portions of the exhibit have been omitted because they (i) are not material and (ii) would likely cause competitive\nharm to the Registrant if publicly disclosed) (9)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221001811/ex10-1.htm)\n\n10.9\n \n[Amendment\n(portions of the exhibit have been omitted because they (i) are not material and (ii) would likely cause competitive harm to the\nRegistrant if publicly disclosed) (9)](https://www.sec.gov/Archives/edgar/data/1413119/000149315221001811/ex10-2.htm)\n\n10.10\n \n[Standby\nEquity Purchase Agreement dated as of January 21, 2025, by and between the Company and YA II PN, LTD. (10)](https://www.sec.gov/Archives/edgar/data/1413119/000149315225003093/ex10-1.htm)\n\n31.1 \n \n[Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)](ex31-1.htm)\n\n31.2\n \n[Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)](ex31-2.htm)\n\n32.1\n \n[Certification of the Principal Executive Officer pursuant to U.S.C. Section 1350 As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)](ex32-1.htm)\n\n32.2\n \n[Certification of the Principal Financial Officer pursuant to U.S.C. Section 1350 As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)](ex32-2.htm)\n\n101.INS\n \nInline\nXBRL Instance Document (filed herewith)\n\n101.SCH\n \nInline\nXBRL Taxonomy Extension Schema Document\n\n101.CAL\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n1.\nIncorporated\nby reference to our Registration Statement on Form SB-2 (Reg. No. 333-146316) filed with the SEC on September 26, 2007.\n\n2.\nIncorporated\nby reference to our Registration Statement on Form S-1 (Reg. No. 333-162316) filed with the SEC on October 2, 2009.\n\n3.\nIncorporated\nby reference to our Current Report on Form 8-K filed with the SEC on November 22, 2013.\n\n4.\nIncorporated\nby reference to our Current Report on Form 8-K filed with the SEC on December 19, 2013.\n\n5.\nIncorporated\nby reference to our Annual Report on Form 10-K filed with the SEC on March 31, 2015.\n\n6.\nIncorporated\nby reference to our Current Report on Form 8-K filed with the SEC on January 21, 2015.\n\n7.\nIncorporated\nby reference to our Current Report on Form 8-K filed with the SEC on March 11, 2019.\n\n8.\nIncorporated\nby reference to our Current Report on Form 8-K filed with the SEC on March 26, 2021.\n\n9.\nIncorporated\nby reference to our Current Report on Form 8-K filed with the SEC on January 26, 2021.\n\n10.\nIncorporated\nby reference to Exhibit 10.1 our Current Report on Form 8-K filed with the SEC on January 21, 2025.\n\n \n\n40\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf of\nthe undersigned thereunto duly authorized.\n\n \n\n \n**Kraig\nBiocraft Laboratories, Inc.**\n\n \n(Registrant)\n\n \n \n\nDate:\nMay 14, 2026\nBy:\n*/s/\nKim Thompson*\n\n \n \nKim\nThompson\n\n \n \nPresident,\nChief Executive Officer and\n\n \n \nChief\nFinancial Officer (Principal Executive Officer and\n\n \n \nPrincipal\nFinancial and Accounting Officer)\n\n \n\n41"}